Vera Therapeutics (VERA) Total Current Liabilities (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Total Current Liabilities came in at $45.1 million in Q1 2026, up 106.22% YoY from $21.9 million in Q1 2025, and down 15.54% on a QoQ basis from $53.5 million in Q4 2025.
Vera Therapeutics (VERA) Total Current Liabilities (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Total Current Liabilities data on file, last reported at $45.1 million in Q1 2026.
- Quarterly Total Current Liabilities rose 106.22% year-over-year to $45.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.1 million (up 106.22% YoY) and the FY2025 annual result came in at $53.5 million, up 110.69% from the prior year.
- Total Current Liabilities eased to $45.1 million in Q1 2026, from $53.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $53.5 million in Q4 2025 to a low of $14.5 million in Q1 2024.
- A 5-year average of $26.9 million and a median of $24.6 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 432.08% — and 2024, when it tumbled 38.19%.
- Tracing VERA's Total Current Liabilities over 5 years: stood at $25.6 million in 2022, then declined by 12.88% to $22.3 million in 2023, then gained by 13.76% to $25.4 million in 2024, then surged by 110.69% to $53.5 million in 2025, then fell by 15.54% to $45.1 million in 2026.
- The last three Total Current Liabilities figures came in at $45.1 million (Q1 2026), $53.5 million (Q4 2025), and $41.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 48.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.32 Mn |
| Mar 31, 2026 | 45.15 Mn |
| Dec 31, 2025 | 53.46 Mn |
| Sep 30, 2025 | 41.88 Mn |
| Jun 30, 2025 | 33.55 Mn |
| Mar 31, 2025 | 21.89 Mn |
| Dec 31, 2024 | 25.37 Mn |
| Sep 30, 2024 | 26.46 Mn |
| Jun 30, 2024 | 18.42 Mn |
| Mar 31, 2024 | 14.54 Mn |
| Dec 31, 2023 | 22.30 Mn |
| Sep 30, 2023 | 24.62 Mn |
| Jun 30, 2023 | 26.84 Mn |
| Mar 31, 2023 | 23.53 Mn |
| Dec 31, 2022 | 25.60 Mn |
| Sep 30, 2022 | 15.92 Mn |
| Jun 30, 2022 | 17.28 Mn |
| Mar 31, 2022 | 19.97 Mn |
| Dec 31, 2021 | 7.69 Mn |
| Sep 30, 2021 | 4.04 Mn |